Charles River Laboratories

Cell and gene therapy continues to revolutionize healthcare, with groundbreaking advancements shaping the future of medicine. Our #EurekaBlog explores what’s trending in 2025, from emerging technologies to new therapeutic approaches. Stay ahead of the curve in this dynamic field: https://okt.to/QebhFC #cellandgenetherapy

Join Mary Parker as Sounds of Science rings in 2025 with episodes on a family’s battle with Batten disease and how advanced technologies are ushering in a new era of drug development. https://okt.to/oAUqgD

Join us at #SLAS2025, the center stage for the latest life sciences and research laboratory technology. You can find us at booth 1343. Charles River Laboratories Discovery | Charles River

Raleigh RMS recently hosted an exciting STEM education volunteer event, welcoming students from the Young Explorers Educational Center for an onsite presentation and tour. Our employees introduced the students to our research models and mission, offering them a firsthand look at our work and its impact. A special thank you to Jolenay Johnson and all our staff members who helped inspire the next generation of scientists. Helping others grow is essential to building a sustainable future. #LIFEatCRL #STEM

Emerging research reveals that microplastics can accumulate in the brain and potentially disrupt blood flow, raising concerns about their long-term impact on human health. Understanding these effects is crucial as we continue to explore the implications of microplastic exposure. Read more about this important study: https://okt.to/J8d7af #EurekaBlog #ScienceTicker #ScienceNews

Charles River has been chosen to receive Scientist.com's Supplier Recognition Award for 2024. This award acknowledges our exceptional contributions as a top marketplace supplier on Scientist.com, helping to significantly enhance the efficiency and speed of research for scientists worldwide. We're honored to be recognized for our commitment to providing high-quality research services. #DrugDiscovery #Biotech #Pharma

PDX tumor organoids are transforming #oncology research by providing a more predictive and patient-specific approach to drug testing. This innovative model bridges the gap between traditional preclinical studies and clinical outcomes, helping researchers advance therapies with greater confidence and efficiency. Explore how this breakthrough technology is shaping the future of #drugdiscovery: https://okt.to/0mI4st

We were thrilled to be recognized as a finalist for the CDMO of the Year award at last night's Phacilitate Advanced Therapies Awards. As a concept to cure provider that has supported the development of 20 FDA-approved cell and gene therapies, the award recognizes our manufacturing excellence, platform innovation, industry impact on drug development, as well as our quality and regulatory expertise. We are grateful for everyone in manufacturing who works daily toward the shared mission of improving the quality of people’s lives. Matthew Hewitt Debiparna Chakraborty Kerstin Dolph Alan Smith Ian Wyllie Kelley Lancaster Dr. Ramin Baghirzade Tim Keen Zane Honnold #atw25 #advancedtherapies #advancedtherapiesweek #cellandgenetherapy #cdmo

This episode of Molecule to Market features Kerstin Dolph discussing the bright future of the biotech market with host, Raman Sehgal. Kerstin shares insight on how companies can innovate to meet changing demands and bring testing and manufacturing together on a global scale. They also dive into the importance of staying connected with patients and the vital role of mentorship in career growth. Learn how we are responding to industry needs and supporting early-stage biotechnology companies through the new Charles River Incubator Program: https://bit.ly/4i8aRnS

Live from #ATW25, Kerstin Dolph discusses the launch of Charles River’s Incubator Program, designed to help early-stage developers overcome this translation hurdle, with scientific advisory services and capabilities to bolster programs from concept to cure. Explore the benefits: https://bit.ly/40tN4qi Learn more about the program: https://bit.ly/4apDxVO